282 related articles for article (PubMed ID: 20003868)
21. Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions.
Chaitman BR
Circulation; 2006 May; 113(20):2462-72. PubMed ID: 16717165
[No Abstract] [Full Text] [Related]
22. Management of chronic stable angina pectoris.
Rodríguez-Ospina L; Montano-Soto L
Bol Asoc Med P R; 2008; 100(4):39-47. PubMed ID: 19400528
[TBL] [Abstract][Full Text] [Related]
23. Ranolazine: new approach for the treatment of stable angina pectoris.
Stanley WC
Expert Rev Cardiovasc Ther; 2005 Sep; 3(5):821-9. PubMed ID: 16181027
[TBL] [Abstract][Full Text] [Related]
24. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
Rousseau MF; Pouleur H; Cocco G; Wolff AA
Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
[TBL] [Abstract][Full Text] [Related]
25. Ranolazine: an antianginal drug with antiarrhythmic properties.
Tamargo J; Caballero R; Delpón E
Expert Rev Cardiovasc Ther; 2011 Jul; 9(7):815-27. PubMed ID: 21809962
[TBL] [Abstract][Full Text] [Related]
26. Measuring antianginal drug efficacy using exercise testing for chronic angina: improved exercise performance with ranolazine, a pFOX inhibitor.
Chaitman BR
Curr Probl Cardiol; 2002 Dec; 27(12):527-55. PubMed ID: 12501118
[No Abstract] [Full Text] [Related]
27. Ranolazine: a new approach to management of patients with angina.
Tafreshi MJ; Fisher E
Ann Pharmacother; 2006 Apr; 40(4):689-93. PubMed ID: 16595572
[TBL] [Abstract][Full Text] [Related]
28. Ranolazine in the management of chronic stable angina.
Zerumsky K; McBride BF
Am J Health Syst Pharm; 2006 Dec; 63(23):2331-8. PubMed ID: 17106005
[TBL] [Abstract][Full Text] [Related]
29. Ranolazine as add-on therapy for patients with severe chronic angina.
Pechlaner C; Wiedermann C
JAMA; 2004 Apr; 291(16):1959; author reply 1959-60. PubMed ID: 15113811
[No Abstract] [Full Text] [Related]
30. Ranolazine: a review of its use as add-on therapy in patients with chronic stable angina pectoris.
Keating GM
Drugs; 2013 Jan; 73(1):55-73. PubMed ID: 23329466
[TBL] [Abstract][Full Text] [Related]
31. Effects of ranolazine on cardiovascular system.
Bonadei I; Vizzardi E; Quinzani F; Piovanelli B; Rovetta R; D'Aloia A; Cas LD
Recent Pat Cardiovasc Drug Discov; 2011 Sep; 6(3):215-21. PubMed ID: 21867482
[TBL] [Abstract][Full Text] [Related]
32. Ranolazine: a review of its use in chronic stable angina pectoris.
Keating GM
Drugs; 2008; 68(17):2483-503. PubMed ID: 19016575
[TBL] [Abstract][Full Text] [Related]
33. Clinical experience with ranolazine in a veteran population with chronic stable angina.
Reeder DN; Gillette MA; Franck AJ; Frohnapple DJ
Ann Pharmacother; 2012 Jan; 46(1):42-50. PubMed ID: 22215689
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial.
Wilson SR; Scirica BM; Braunwald E; Murphy SA; Karwatowska-Prokopczuk E; Buros JL; Chaitman BR; Morrow DA
J Am Coll Cardiol; 2009 Apr; 53(17):1510-6. PubMed ID: 19389561
[TBL] [Abstract][Full Text] [Related]
35. Myopathy during treatment with the antianginal drug ranolazine.
Kassardjian CD; Tian X; Vladutiu G; Wong LJ; Milone M
J Neurol Sci; 2014 Dec; 347(1-2):380-2. PubMed ID: 25466697
[TBL] [Abstract][Full Text] [Related]
36. [Chronic ischemic heart diseases. Effectively alleviating ischemia symptoms].
MMW Fortschr Med; 2012 Oct; 154(18):80-1. PubMed ID: 23156882
[No Abstract] [Full Text] [Related]
37. Ranolazine: a novel agent that improves dysfunctional sodium channels.
Pham DQ; Mehta M
Int J Clin Pract; 2007 May; 61(5):864-72. PubMed ID: 17493093
[TBL] [Abstract][Full Text] [Related]
38. Ranolazine refractory angina registry: 1-year results.
Bennett NM; Iyer V; Arndt TL; Garberich RF; Traverse JH; Johnson RK; Poulose AK; Lips A; Morgan JM; Henry TD
Crit Pathw Cardiol; 2014 Sep; 13(3):96-8. PubMed ID: 25062392
[TBL] [Abstract][Full Text] [Related]
39. [New agents for the therapy of angina pectoris].
Meinertz T; Köster R
Internist (Berl); 2011 Jul; 52(7):894-6, 898-900. PubMed ID: 21713611
[TBL] [Abstract][Full Text] [Related]
40. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem.
Cocco G; Rousseau MF; Bouvy T; Cheron P; Williams G; Detry JM; Pouleur H
J Cardiovasc Pharmacol; 1992 Jul; 20(1):131-8. PubMed ID: 1383622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
